HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of autophagosome formation restores mitochondrial function in mucolipidosis II and III skin fibroblasts.

Abstract
Mucolipidosis II and III are progressive lysosomal storage disorders caused by a deficiency of N-acetylglucosamine-1-phosphotransferase, leading to massive accumulation of undigested substrates in lysosomes (inclusion bodies) in skin fibroblast. In this study, we demonstrated accumulation of autolysosomes and increased levels of p62 and ubiquitin proteins in cultured fibroblasts. These autophagic elevations were milder in mucolipidosis III compared with mucolipidosis II. Mitochondrial structure was fragmented and activity was impaired in the affected cells, and 3-methyladenine, an inhibitor of autophagosome formation, restored these. These results show for the first time autophagic and mitochondrial dysfunctions in this disorder.
AuthorsTakanobu Otomo, Katsumi Higaki, Eiji Nanba, Keiichi Ozono, Norio Sakai
JournalMolecular genetics and metabolism (Mol Genet Metab) Vol. 98 Issue 4 Pg. 393-9 (Dec 2009) ISSN: 1096-7206 [Electronic] United States
PMID19656701 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • SQSTM1 protein, human
  • Sequestosome-1 Protein
  • Ubiquitinated Proteins
  • Cathepsin B
  • Cathepsin D
Topics
  • Adaptor Proteins, Signal Transducing (metabolism)
  • Autophagy
  • Cathepsin B (metabolism)
  • Cathepsin D (metabolism)
  • Fibroblasts (enzymology, pathology)
  • Humans
  • Inclusion Bodies (metabolism)
  • Lysosomes (metabolism, pathology)
  • Mitochondria (metabolism)
  • Mucolipidoses (enzymology, pathology, physiopathology)
  • Phagosomes (metabolism, pathology)
  • Protein Transport
  • Sequestosome-1 Protein
  • Skin (pathology)
  • Subcellular Fractions (enzymology)
  • Ubiquitinated Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: